NCT04924985

Brief Summary

The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1) Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

February 11, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

3.5 years

First QC Date

June 10, 2021

Last Update Submit

March 24, 2025

Conditions

Keywords

CPR

Outcome Measures

Primary Outcomes (1)

  • Rate of Return of Spontaneous Circulation (ROSC)

    Day 0

Secondary Outcomes (6)

  • Cerebral Performance Category (CPC) Score

    Day 1-2

  • Cerebral Performance Category (CPC) Score

    Day 30

  • Change in mean rSO2 during CPR as markers of the quality of resuscitation

    Day 0

  • Change in mean ETCO2 during CPR as markers of the quality of resuscitation

    Day 0

  • Release of interleukin (IL)-6

    Day 0

  • +1 more secondary outcomes

Study Arms (2)

Physiological Feedback CPR

EXPERIMENTAL
Other: Physiological Feedback CPR

Non-Physiological (Audiovisual) Feedback CPR

ACTIVE COMPARATOR
Other: Non-Physiological Feedback CPR

Interventions

Non-physiologically guided CPR using AV feedback (integrated into defibrillators)

Non-Physiological (Audiovisual) Feedback CPR

Physiological feedback CPR using an optimal regional O2 Saturation (rSO2), End-tidal CO2 (ETCO2) or combined (rSO2/ETCO2) target

Physiological Feedback CPR

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In-hospital cardiac arrest patient
  • Age ≥18 years
  • Age \<80 years
  • CPR lasting ≥5 minutes

You may not qualify if:

  • Patients \< 18 years of age or \> 80 years of age
  • Out of hospital cardiac arrest patients
  • ≥3 acute organ failures (defined as acute renal failure requiring dialysis, fulminant liver failure i.e. liver failure with INR≥1.5, respiratory failure requiring mechanical ventilation)
  • Repeat in-hospital cardiac arrest event within 14 days of a prior cardiac arrest
  • Presence of known raised intracranial pressure
  • Presence of known traumatic brain injury or subarachnoid hemorrhage \<14 days old, frontal lobe brain tumors or subdural hemorrhage
  • Hyperbilirubinemia \>1.0 mg/dl (based on the absorption of near-infrared light by bilirubin)
  • Resuscitation using extra-corporeal membrane oxygenation (ECMO)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

IschemiaReperfusion Injury

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular DiseasesPostoperative Complications

Study Officials

  • Sam Parnia, MD, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 14, 2021

Study Start

February 11, 2022

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

March 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Sam.Parnia@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations